Literature DB >> 3389892

Androstenedione rhythms in saliva in congenital adrenal hyperplasia.

M C Young1, R F Walker, D Riad-Fahmy, I A Hughes.   

Abstract

Serial samples of saliva were collected at home by 17 patients being treated for congenital adrenal hyperplasia to determine the circadian rhythm of androstenedione as an index of therapeutic control. Single samples of blood for measurement of plasma testosterone, 170H-progesterone, and androstenedione concentrations were collected from these and a further seven patients for comparison. Plasma androstenedione concentrations showed a close correlation with plasma concentrations of 170H-progesterone and testosterone. There was a strong correlation between the salivary androstenedione profiles and plasma testosterone concentrations in pubertal girls. Concentrations of androstenedione in saliva decreased during the day but remained raised at each sampling time in relation to plasma testosterone concentrations. Salivary androstenedione profiles are shown as nomograms to distinguish the degree of therapeutic control. The concentration of androstenedione, measured in plasma or saliva, is an alternative marker to monitor control of treatment in congenital adrenal hyperplasia. The measurement in saliva is a useful index of androgen production when blood sampling is difficult.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3389892      PMCID: PMC1778886          DOI: 10.1136/adc.63.6.624

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

1.  Hormonal changes in puberty III: Correlation of plasma dehydroepiandrosterone, testosterone, FSH, and LH with stages of puberty and bone age in normal boys and girls and in patients with Addison's disease or hypogonadism or with premature or late adrenarche.

Authors:  P C Sizonenko; L Paunier
Journal:  J Clin Endocrinol Metab       Date:  1975-11       Impact factor: 5.958

2.  A simple robust assay for testosterone in male plasma using an 125I-radioligand and a solid-phase separation technique.

Authors:  J Dyas; G F Read; D Riad-Fahmy
Journal:  Ann Clin Biochem       Date:  1979-11       Impact factor: 2.057

3.  The relationships between serum concentrations of 17OH-progesterone and other serum and urinary steroids in patients with congenital adrenal hyperplasia.

Authors:  I A Hughes; J S Winter
Journal:  J Clin Endocrinol Metab       Date:  1978-01       Impact factor: 5.958

4.  Plasma adrenal and gonadal sex steroids in human pubertal development.

Authors:  J R Ducharme; M G Forest; E De Peretti; M Sempé; R Collu; J Bertrand
Journal:  J Clin Endocrinol Metab       Date:  1976-03       Impact factor: 5.958

5.  170H-progesterone rhythms in congenital adrenal hyperplasia.

Authors:  M C Young; J A Robinson; G F Read; D Riad-Fahmy; I A Hughes
Journal:  Arch Dis Child       Date:  1988-06       Impact factor: 3.791

  5 in total
  8 in total

Review 1.  Management of congenital adrenal hyperplasia.

Authors:  I A Hughes
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

Review 2.  Mutual Shaping of Circadian Body-Wide Synchronization by the Suprachiasmatic Nucleus and Circulating Steroids.

Authors:  Yifan Yao; Rae Silver
Journal:  Front Behav Neurosci       Date:  2022-06-01       Impact factor: 3.617

3.  Prevalence of congenital adrenal hyperplasia in Kuwait.

Authors:  M M Lubani; A R Issa; R Bushnaq; Q A al-Saleh; K I Dudin; P C Reavey; M Y el-Khalifa; D S Manandhar; Y K Abdul Al; E A Ismail
Journal:  Eur J Pediatr       Date:  1990-03       Impact factor: 3.183

4.  Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia.

Authors:  Andrew Dauber; Henry A Feldman; Joseph A Majzoub
Journal:  Int J Pediatr Endocrinol       Date:  2010-09-14

Review 5.  Steroid assays in paediatric endocrinology.

Authors:  John W Honour
Journal:  J Clin Res Pediatr Endocrinol       Date:  2010-02-01

6.  Optimizing the Timing of Highest Hydrocortisone Dose in Children and Adolescents With 21-Hydroxylase Deficiency.

Authors:  Mariska A M Schröder; Antonius E van Herwaarden; Paul N Span; Erica L T van den Akker; Gianni Bocca; Sabine E Hannema; Hetty J van der Kamp; Sandra W K de Kort; Christiaan F Mooij; Dina A Schott; Saartje Straetemans; Vera van Tellingen; Janiëlle A van der Velden; Fred C G J Sweep; Hedi L Claahsen-van der Grinten
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

7.  Diurnal salivary androstenedione and 17-hydroxyprogesterone levels in healthy volunteers for monitoring treatment efficacy of patients with congenital adrenal hyperplasia.

Authors:  Bas P H Adriaansen; Johannes S Kamphuis; Mariska A M Schröder; André J Olthaar; Carina Bock; André Brandt; Nike M M L Stikkelbroeck; Eef G W M Lentjes; Paul N Span; Fred C G J Sweep; Hedi L Claahsen-van der Grinten; Antonius E van Herwaarden
Journal:  Clin Endocrinol (Oxf)       Date:  2022-02-23       Impact factor: 3.523

8.  Differential effects of hydrocortisone, prednisone, and dexamethasone on hormonal and pharmacokinetic profiles: a pilot study in children with congenital adrenal hyperplasia.

Authors:  Todd D Nebesio; Jamie L Renbarger; Zeina M Nabhan; Sydney E Ross; James E Slaven; Lang Li; Emily C Walvoord; Erica A Eugster
Journal:  Int J Pediatr Endocrinol       Date:  2016-09-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.